First Citizens Bank & Trust Co. Sells 1,907 Shares of DaVita Inc. (NYSE:DVA)

First Citizens Bank & Trust Co. trimmed its holdings in shares of DaVita Inc. (NYSE:DVA) by 8.7% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 20,091 shares of the company’s stock after selling 1,907 shares during the quarter. First Citizens Bank & Trust Co.’s holdings in DaVita were worth $3,005,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. Franklin Resources Inc. grew its holdings in DaVita by 134.6% during the third quarter. Franklin Resources Inc. now owns 54,901 shares of the company’s stock valued at $8,885,000 after purchasing an additional 31,502 shares during the period. FMR LLC grew its holdings in DaVita by 659.9% during the third quarter. FMR LLC now owns 177,406 shares of the company’s stock valued at $29,082,000 after purchasing an additional 154,061 shares during the period. Atom Investors LP acquired a new position in shares of DaVita in the third quarter valued at approximately $4,094,000. Assenagon Asset Management S.A. boosted its holdings in shares of DaVita by 201.7% in the fourth quarter. Assenagon Asset Management S.A. now owns 74,617 shares of the company’s stock valued at $11,159,000 after buying an additional 49,885 shares during the period. Finally, Neo Ivy Capital Management acquired a new position in shares of DaVita in the third quarter valued at approximately $726,000. 90.12% of the stock is owned by institutional investors.

DaVita Stock Performance

Shares of DVA stock opened at $170.06 on Monday. The company’s fifty day simple moving average is $158.32 and its 200-day simple moving average is $154.01. The company has a quick ratio of 1.33, a current ratio of 1.37 and a debt-to-equity ratio of 15.78. The firm has a market cap of $13.94 billion, a PE ratio of 18.35, a P/E/G ratio of 0.82 and a beta of 0.92. DaVita Inc. has a 12 month low of $104.70 and a 12 month high of $170.80.

DaVita (NYSE:DVA) last announced its quarterly earnings data on Tuesday, October 29th. The company reported $2.59 EPS for the quarter, missing analysts’ consensus estimates of $2.76 by ($0.17). The business had revenue of $3.26 billion during the quarter, compared to the consensus estimate of $3.25 billion. DaVita had a return on equity of 88.18% and a net margin of 6.53%. The business’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.85 EPS. Equities research analysts expect that DaVita Inc. will post 9.71 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on DVA shares. Truist Financial upped their price target on shares of DaVita from $165.00 to $175.00 and gave the company a “hold” rating in a report on Monday, October 7th. Barclays upped their price target on shares of DaVita from $150.00 to $164.00 and gave the company an “equal weight” rating in a report on Thursday, October 31st. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $161.80.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.